ANGELA BENREY: Open Payments
NPI 1245940907 · RICHMOND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 18 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $376 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $98 |
| ABBVIE INC. | 3 | $67 |
| Madrigal Pharmaceuticals | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Ardelyx, Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| EVOKE PHARMA, INC. | 1 | $14 |
Products named: DUPIXENT, REZDIFFRA, XIFAXAN, IBSRELA, LINZESS, MAVYRET, RINVOQ, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
